ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)

ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)

No trades
See on Supercharts

Key facts today

Eli Lilly & Co experienced a 2.1% decline in market capitalization while continuing to lead in the diabetes and weight loss drug markets.
Analyze the impactAnalyze the impact
Market capitalization
‪789.39 B‬USD
0.129USD
‪1.91 B‬USD
‪12.43 B‬USD
Beta (1Y)
0.30

About Eli Lilly and Company


CEO
David A. Ricks
Headquarters
Indianapolis
Website
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFVYP1
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US532457AM0
ELI LILLY 2025
Yield to maturity
5.71%
Maturity date
Jun 1, 2025
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.39%
Maturity date
Jun 15, 2044
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.24%
Maturity date
Aug 14, 2064
LLY.GG
Eli Lilly and Company 6.77% 01-JAN-2036
Yield to maturity
5.23%
Maturity date
Jan 1, 2036
US532457BS6
ELI LILLY 19/39
Yield to maturity
5.23%
Maturity date
Mar 15, 2039
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.22%
Maturity date
Feb 9, 2064
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.21%
Maturity date
Feb 27, 2063
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047
Yield to maturity
5.16%
Maturity date
May 15, 2047
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054
Yield to maturity
5.16%
Maturity date
Aug 14, 2054
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054
Yield to maturity
5.14%
Maturity date
Feb 9, 2054
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053
Yield to maturity
5.14%
Maturity date
Feb 27, 2053

Explore more bonds